Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Today marks the launch of a new Oxford-wide initiative – the Oxford Centre for Haematology (OCH).

This virtual Centre aims to promote integration between academic and clinical haematology programmes in the University and Oxford University Hospitals NHS Foundation Trust and thereby capitalise on scientific opportunities to transform our understanding of haematopoiesis and blood diseases, with the goal of radically improving patient care.

The OCH will be led by Prof Paresh Vyas, a member of the MRC Molecular Haematology Unit based at the MRC WIMM, and several of the centre’s members are based at our Institute.

OCH builds on over 40 years of haematology research excellence in Oxford. From the pioneering work on globins led by our founder Professor Sir David Weatherall, Prof John Clegg and Prof Doug Higgs, through to our current position of driving the largest blood cancer clinical trials program in the UK, Oxford is truly a powerhouse of haematology research. OCH will build on, and enhance, our understanding of blood cancers, ageing of the haematopoietic system and the links with inflammation and immunity. The Centre will also raise new funding for research, trials and implementation into clinical practice, alongside training the next generation of scientists and healthcare professionalsand encouraging partnerships.

Establishing the Centre has been made possible thanks to funding from the NIHR Oxford Biomedical Research Centre and will be hosted by RDM, embedded within the Nuffield Division of Clinical Laboratory Sciences.

More information can be found here and all are invited to attend the OCH Inaugural Symposium on the 26 March.

Please direct any questions about OCH to Julie Stevens,whose desk is based in the WIMM’s Administration Office.

Similar stories

2022 RDM Graduate Prize Winners

This year's RDM winners are Edward Jenkins, Antje Rottner, and Akshay Shah.

Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing

The biotechnology company builds upon research conducted by Professor Jim Hughes and Prof. James Davies at the MRC Weatherall Institute of Molecular Medicine, and combines 3D genome technology and machine learning to decode the dark matter of the human genome.

KJ Patel appointed new Chief Scientist of CRUK

Alongside his new role at Cancer Research UK, Prof. Patel will continue as the Director of both the MRC Weatherall Institute for Molecular Medicine (MRC WIMM) and the MRC Molecular Haematology Unit (MRC MHU).

September is Childhood Cancer Awareness Month

September is Childhood Cancer Awareness Month, where our Childhood Leukaemia research group have taken action to help raise awareness for this cause.

Anjali Kusumbe receives the RMS Life Sciences Medal

The Royal Microscopical Society awards celebrate the best in microscopy, recognising those making a special contribution to microscopy, cytometry and imaging.